[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349985-105":59,"doc-detail-349985-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","pathophysiological-significance-of-the-trpm2-ion-channel-as-a-potential-target-in-cancer-neurological-disorders-and-ischemia-reperfusion-injury","Pathophysiological significance of the TRPM2 ion channel as a potential target in cancer, neurological disorders, and ischemia - reperfusion injury","","The transient receptor potential melastatin 2 (TRPM2) ion channel is a redox-sensitive, nonspecific cation channel that regulates Ca2+ homeostasis and cellular functions under oxidative stress. Aberrant TRPM2 expression is linked to multiple diseases: overexpression supports survival in several malignancies, while TRPM2 also participates in Alzheimer’s disease, Parkinson’s disease, epilepsy, and ischemia/reperfusion injury. This review integrates structural features, regulation, oxidative-stress signaling, and mechanistic pathways, highlighting therapeutic potential, TRPM2-AS, and current TRPM2 inhibitors with SAR, PK, preclinical efficacy, and limitations.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/pathophysiological-significance-of-the-trpm2-ion-channel-as-a-potential-target-in-cancer-neurological-disorders-and-ischemia-reperfusion-injury/349985/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/pathophysiological-significance-of-the-trpm2-ion-channel-as-a-potential-target-in-cancer-neurological-disorders-and-ischemia-reperfusion-injury/349985.png","ImageObject",300,407,{"name":92,"@type":93},"Mia  ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What biological role does TRPM2 play under oxidative stress?","Question",{"text":112,"@type":113},"TRPM2 is a redox-sensitive cation channel that supports intracellular Ca2+ homeostasis and coordinates cellular responses to oxidative stress.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How is TRPM2 linked to cancer progression?",{"text":117,"@type":113},"Aberrant TRPM2 expression, particularly overexpression, promotes cell survival and supports tumor progression in multiple malignancies.",{"name":119,"@type":110,"acceptedAnswer":120},"What therapeutic strategies and inhibitor types are reviewed for TRPM2?",{"text":121,"@type":113},"The review discusses the therapeutic potential of TRPM2, including TRPM2-AS, and provides an overview of currently available TRPM2 inhibitors such as ADPR analogs, small molecules, and peptides, covering SAR, PK, efficacy, and shortcomings.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},349985,1791472770,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":24,"preview_urls":146},687207024478,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Author Manuscript Author Manuscript Author Manuscript Author Manuscript  \n\n| | HHS Public Access\u003Cbr>Author manuscript\u003Cbr>Pharmacol Res. Author manuscript; available in PMC 2026 March 19. |\n| --- | --- |\n\nPublished in final edited form as:  \nPharmacol Res. 2026 March ; 225: 108132. doi:10.1016/j.phrs.2026.108132 .  \nPathophysiological significance of the TRPM2 ion channel as a potential target in cancer, neurological disorders, and ischemia/ reperfusion injury  \nSara Sultana, Yang Xie, Mir Shahriar Kamal,  \n*  \nWei Li  \nDepartment of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, TN 38163, United States  \nAbstract  \nThe transient receptor potential melastatin 2 (TRPM2) ion channel is a redox-sensitive, nonspecific cation channel that plays a vital role in the regulation of Ca2+ homeostasis and cellular functions in response to oxidative stress. However, aberrant expression ofTRPM2 is associated with various pathological conditions. Overexpression ofTRPM2 promotes cell survival in multiple malignancies, including neuroblastoma, lung, prostate, stomach, and pancreatic cancers. TRPM2 also mediates different neurological disorders, such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and epilepsy, and contributes to ischemia/reperfusion (I/R) injury. This review provides a comprehensive summary of the pathophysiological significance ofTRPM2, covering the structural features, regulation, and oxidative stress signaling, with a major focus on the mechanistic pathways that link TRPM2 to these diseases. We discuss the therapeutic potential of TRPM2, its long non-coding antisense RNA (TRPM2-AS), and provide a comprehensive overview of currently available TRPM2 inhibitors, including adenosine diphosphate ribose (ADPR) analogs, small molecules, and peptides. This review covers an in-depth analysis of the structural activity relationships (SAR), pharmacokinetic (PK) properties of these TRPM2 inhibitors, detailing their preclinical efficacy studies, and outlining their shortcomings. Overall, we conclude that TRPM2 represents a promising drug target for effective therapies in several major disease indications.  \nThis is an open access article under the CC BY-NC-ND license ([http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/)).  \n*[Corresponding author. wli@uthsc.edu](Corresponding author. wli@uthsc.edu) (W. Li) .  \nCRediT authorship contribution statement  \nYang Xie: Writing – review & editing, Writing – original draft. Sara Sultana: Writing – review & editing, Writing – original draft, Visualization, Conceptualization. Wei Li: Writing – review & editing, Writing – original draft, Supervision, Resources, Project administration, Funding acquisition, Conceptualization. Mir Shahriar Kamal: Writing – review & editing, Writing – original draft, Visualization.  \nDeclaration of Competing Interest  \nAll authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.  \nAuthor Manuscript Author Manuscript Author Manuscript Author Manuscript  \nSultana et al. Page 2  \nKeywords  \nTRPM2 inhibitors; Oxidative stress; Ca2+ influx; Cancer; Neurological disorders; Ischemia/ reperfusion (I/R) injury  \n1. Introduction  \nThe transient receptor potential melastatin 2 (TRPM2) ion channel belongs to the transient receptor potential melastatin (TRPM) subfamily of the transient receptor potential (TRP) superfamily. TRP channels constitute a large and functionally diverse group of tetrameric, non-selective cation channels that were originally identified in Drosophila melanogaster and later in mammals and various other species. In mammals, the TRP superfamily is classified into six major subfamilies: TRPA (ankyrin), TRPC (canonical), TRPM (melastatin), TRPV (vanilloid), TRPML (mucolipin), and TRPP (polycystin). Among these, the TRPM subfamily is the most diverse and ubiquitously ","cbCaiotmnAR83lF5","https://ap.wps.com/l/cbCaiotmnAR83lF5","pdf",2986637,47,"English","# Abstract\n# 1. Introduction\n## TRPM2 in the TRP superfamily\n## Structural features and Ca2+ homeostasis\n## Tissue distribution and downstream functions\n## Pathological roles under sustained activation\n## TRPM2 as a mediator in oxidative stress diseases","[{\"question\":\"What biological role does TRPM2 play under oxidative stress?\",\"answer\":\"TRPM2 is a redox-sensitive cation channel that supports intracellular Ca2+ homeostasis and coordinates cellular responses to oxidative stress.\"},{\"question\":\"How is TRPM2 linked to cancer progression?\",\"answer\":\"Aberrant TRPM2 expression, particularly overexpression, promotes cell survival and supports tumor progression in multiple malignancies.\"},{\"question\":\"What therapeutic strategies and inhibitor types are reviewed for TRPM2?\",\"answer\":\"The review discusses the therapeutic potential of TRPM2, including TRPM2-AS, and provides an overview of currently available TRPM2 inhibitors such as ADPR analogs, small molecules, and peptides, covering SAR, PK, efficacy, and shortcomings.\"}]","Pathophysiological significance of the TRPM2 ion channel as a potential target in cancer, neurological disorders, and ischemia - reperfusion injury | PDF",1790086590,118,[147,151,155,159,163],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f04d704f985091ae654a601bd0afee41.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5fd5b48fb0096ce9eb075d4ee57e9b74.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bfd5d9bd717979d43e8739726745e9d9.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/50e7aadbe0ab76d7a47a0b46b23c8064.webp",980,1268,{"page_no":24,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e5f70a272327cb0ffb33c5f666124387.webp",979,1267]